The leading source for credible citizen reporting

Help | Login | Join Allvoices

Mainstream News

This event is older than two months and is no longer active. Some links older than two months could be broken.

Click here to post a new related report

New name, CEO for Nastech

Source: Seattle Times

Bothell : WA : USA | about 1 year ago

0 0

French last year steered Sirna Therapeutics to a $1.1 billion sale to Merck...Quay, at Nastech's helm for eight years, will become chief scientific officer and remain chairman. RNA interference, the same type of products that spurred the acquisition of San Francisco-based Sirna by Merck.

Reach
Credibility

More News From: Bothell : WA : USA

News Stories

New name, CEO for Nastech

News Source: Seattle Times | about 1 year ago

French last year steered Sirna Therapeutics to a $1.1 billion sale to Merck...Quay, at Nastech's helm for eight years, will become chief scientific officer and remain chairman. RNA interference, the same type of products that spurred the acquisition...
Bothell's Nastech Pharmaceutical has new name, focus

News Source: Herald Net | about 1 year ago

Nastech Pharmaceutical Co. has a new name, stock symbol and chief executive officer today to match a seismic shift in the biotechnology firm's focus. In recent months, the ï¿½Bothell-based company has signaled a desire to focus on RNA interference,...
Nastech hires RNAi veteran as CEO

News Source: Seattle Post Intelligencer | about 1 year ago

Hoping to remake itself as a major player in one of the most promising -- and hyped -- fields in medicine, Bothell's Nastech Pharmaceutical said Tuesday it had hired as its new CEO an executive who previously held a top post at a leading RNA...